KR101792200B1 - 열감응성 겔 마취제 조성물 - Google Patents

열감응성 겔 마취제 조성물 Download PDF

Info

Publication number
KR101792200B1
KR101792200B1 KR1020127028635A KR20127028635A KR101792200B1 KR 101792200 B1 KR101792200 B1 KR 101792200B1 KR 1020127028635 A KR1020127028635 A KR 1020127028635A KR 20127028635 A KR20127028635 A KR 20127028635A KR 101792200 B1 KR101792200 B1 KR 101792200B1
Authority
KR
South Korea
Prior art keywords
composition
castor oil
poloxamer
weight
lidocaine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020127028635A
Other languages
English (en)
Korean (ko)
Other versions
KR20130081653A (ko
Inventor
마크 순드베르그
아르네 브로딘
닐스 칼베르그
Original Assignee
파마네스트 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44502740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101792200(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 파마네스트 아베 filed Critical 파마네스트 아베
Publication of KR20130081653A publication Critical patent/KR20130081653A/ko
Application granted granted Critical
Publication of KR101792200B1 publication Critical patent/KR101792200B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020127028635A 2010-04-01 2011-03-31 열감응성 겔 마취제 조성물 Active KR101792200B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1050321-7 2010-04-01
SE1050321 2010-04-01
US32541810P 2010-04-19 2010-04-19
US61/325,418 2010-04-19
PCT/EP2011/055009 WO2011121074A1 (en) 2010-04-01 2011-03-31 Thermogelling anaesthetic compositions

Publications (2)

Publication Number Publication Date
KR20130081653A KR20130081653A (ko) 2013-07-17
KR101792200B1 true KR101792200B1 (ko) 2017-10-31

Family

ID=44502740

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127028635A Active KR101792200B1 (ko) 2010-04-01 2011-03-31 열감응성 겔 마취제 조성물

Country Status (29)

Country Link
US (3) US8834927B2 (enExample)
EP (1) EP2552487B1 (enExample)
JP (2) JP5972862B2 (enExample)
KR (1) KR101792200B1 (enExample)
CN (1) CN102858374B (enExample)
AU (1) AU2011234492B2 (enExample)
BR (1) BR112012024673B1 (enExample)
CA (1) CA2795154C (enExample)
CL (1) CL2012002706A1 (enExample)
CY (1) CY1118396T1 (enExample)
DK (1) DK2552487T3 (enExample)
EA (1) EA023396B1 (enExample)
ES (1) ES2608850T3 (enExample)
HR (1) HRP20161663T1 (enExample)
HU (1) HUE031107T2 (enExample)
IL (1) IL222224A (enExample)
LT (1) LT2552487T (enExample)
MX (1) MX2012011262A (enExample)
MY (1) MY163215A (enExample)
NZ (1) NZ602538A (enExample)
PH (1) PH12012501886A1 (enExample)
PL (1) PL2552487T3 (enExample)
PT (1) PT2552487T (enExample)
RS (1) RS55544B1 (enExample)
SG (1) SG184071A1 (enExample)
SI (1) SI2552487T1 (enExample)
SM (2) SMT201700050T1 (enExample)
WO (1) WO2011121074A1 (enExample)
ZA (1) ZA201206988B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS55544B1 (sr) * 2010-04-01 2017-05-31 Pharmanest Ab Termogelirajuće anestetičke kompozicije
KR101768843B1 (ko) * 2013-02-28 2017-08-17 미라 파마 코포레이션 주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
GB201305622D0 (en) * 2013-03-27 2013-05-15 Sas Ltd Composition
TW201625232A (zh) * 2014-10-01 2016-07-16 陳建宏 含有阿司匹靈、二甲雙胍和血清素與非離子界面活性劑的醫藥組合物
WO2016152186A1 (ja) 2015-03-25 2016-09-29 テルモ株式会社 ゲル状局所麻酔剤およびそれを用いたゲル状局所麻酔製剤
AU2016352007B2 (en) 2015-11-12 2022-03-17 Terumo Kabushiki Kaisha Sustained-release topically administered agent
CN105769839B (zh) * 2016-05-17 2019-06-11 山西远扬医药科技有限公司 一种复方利多卡因药物组合物及其制备方法
CN107149697B (zh) * 2017-03-24 2020-07-31 王科 一种皮肤表面麻醉敷料、其制备方法及使用方法
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
CN108309928A (zh) * 2018-03-22 2018-07-24 兆科（广州）眼科药物有限公司 一种妇科术后止痛药物组合物及其制备方法
IT201800004036A1 (it) * 2018-03-28 2019-09-28 Teres Srl Gel transdermico
EP3790856A4 (en) * 2018-05-08 2022-03-02 University of Connecticut LONG-ACTING LOCAL ANESTHETIC FORMULATION
CN111840553A (zh) * 2019-04-15 2020-10-30 湖州依诺唯新药物制剂有限公司 脂性药物制剂及其应用
JP7646175B2 (ja) * 2019-11-28 2025-03-17 東洋製薬化成株式会社 リドカイン含有外用医薬組成物
US20230190650A1 (en) * 2020-02-25 2023-06-22 The University Of North Carolina At Chapel Hill Eutectic based anesthetic compositions and applications thereof
US12508221B2 (en) * 2020-09-11 2025-12-30 PS Therapy Ltd Topical compositions and methods of use
JP2025504173A (ja) * 2022-02-04 2025-02-06 インタクト セラピューティクス， インコーポレイテッド メサラミン薬学的製剤およびその使用法
US12514756B1 (en) 2024-10-08 2026-01-06 Covidien Lp Dermal patch and systems, kits, and methods associated therewith

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248014B (it) * 1991-06-07 1995-01-05 Inverni Della Beffa Spa Preparazioni oftalmiche a rilascio protratto
SE9601421D0 (sv) * 1996-04-12 1996-04-12 Astra Ab New composition
US6217900B1 (en) * 1997-04-30 2001-04-17 American Home Products Corporation Vesicular complexes and methods of making and using the same
JP3782551B2 (ja) * 1997-06-24 2006-06-07 鉄郎 高山 鎮痛組成物
US6528086B2 (en) 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
KR100416646B1 (ko) 2000-08-14 2004-02-05 구주제약주식회사 리도카인을 함유한 조루치료용 마이크로에멀젼 하이드로겔 제형의 약학 조성물
GB0120701D0 (en) 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Pharmaceutical formulations
GB0120702D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Anaesthetic formulations
RS54275B1 (sr) * 2002-07-29 2016-02-29 Transform Pharmaceuticals, Inc. Vodeni 2,6-diizopropilfenol farmaceutski sastavi
US20040220283A1 (en) 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
AU2003900887A0 (en) * 2003-02-27 2003-03-13 Novasel Australia Pty Ltd Poloxamer emulsion preparations
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
US20050084508A1 (en) 2003-07-22 2005-04-21 Vancaillie Thierry G. Topical anesthesia formulation for bodily cavities
HUE026644T2 (en) 2004-05-28 2016-07-28 Oryxe A mixture for transdermal delivery of low and high molecular weight compounds
US20070190124A1 (en) 2004-06-07 2007-08-16 Jie Zhang Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
AU2006201233B2 (en) 2006-03-24 2010-10-07 Alan Hewitt Topical anesthesia formulation for bodily cavities
US20070298005A1 (en) 2006-06-22 2007-12-27 Marie-Josee Thibault Injectable composition for treatment of skin defects or deformations
EP2046310B1 (en) * 2006-07-31 2011-11-02 Besins Healthcare Luxembourg SARL Treatment and prevention of excessive scarring
JP5301205B2 (ja) * 2008-05-28 2013-09-25 東興薬品工業株式会社 ゲル軟膏組成物
RS55544B1 (sr) * 2010-04-01 2017-05-31 Pharmanest Ab Termogelirajuće anestetičke kompozicije

Also Published As

Publication number Publication date
HRP20161663T1 (hr) 2017-01-13
RS55544B1 (sr) 2017-05-31
CN102858374B (zh) 2015-12-09
MX2012011262A (es) 2013-02-11
CL2012002706A1 (es) 2013-02-01
PH12012501886A1 (en) 2012-12-17
EP2552487A1 (en) 2013-02-06
IL222224A0 (en) 2012-12-31
AU2011234492B2 (en) 2014-02-27
EA201290789A1 (ru) 2013-04-30
SG184071A1 (en) 2012-10-30
JP2016185950A (ja) 2016-10-27
DK2552487T3 (en) 2017-02-06
US20140155434A1 (en) 2014-06-05
EA023396B1 (ru) 2016-05-31
BR112012024673A2 (pt) 2017-08-08
ZA201206988B (en) 2014-04-30
LT2552487T (lt) 2016-12-27
PL2552487T3 (pl) 2017-04-28
MY163215A (en) 2017-08-30
CA2795154C (en) 2017-04-18
ES2608850T3 (es) 2017-04-17
US8834927B2 (en) 2014-09-16
SMT201700050T1 (it) 2017-03-08
US8828437B2 (en) 2014-09-09
KR20130081653A (ko) 2013-07-17
SMT201700050B (it) 2017-03-08
BR112012024673B1 (pt) 2021-06-29
JP2013523693A (ja) 2013-06-17
US20140329906A1 (en) 2014-11-06
PT2552487T (pt) 2016-12-30
JP5972862B2 (ja) 2016-08-17
HUE031107T2 (en) 2017-06-28
EP2552487B1 (en) 2016-10-19
CA2795154A1 (en) 2011-10-06
US9254263B2 (en) 2016-02-09
NZ602538A (en) 2014-03-28
CY1118396T1 (el) 2017-06-28
SI2552487T1 (sl) 2017-02-28
WO2011121074A1 (en) 2011-10-06
US20130116328A1 (en) 2013-05-09
IL222224A (en) 2015-10-29
AU2011234492A1 (en) 2012-10-18
CN102858374A (zh) 2013-01-02

Similar Documents

Publication Publication Date Title
US9254263B2 (en) Thermogelling anaesthetic compositions
Almeida et al. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): Main features and their applications in topical and transdermal administration of drugs
FI119498B (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
KR20110125660A (ko) 가온성 및 무자극성 윤활제 항진균성 겔 조성물
Abd Ellah et al. Dual-responsive lidocaine in situ gel reduces pain of intrauterine device insertion
US20240108603A1 (en) Material and method for treating cancer
CN102892408A (zh) 适于局部麻醉剂的无水药物组合物
CN104338147B (zh) 一种用于缓控释给药的软膏组合基质
ES2811365T3 (es) Macrogols para aplicación a la mucosa, y sus usos terapéuticos
JP7601802B2 (ja) キシログルカン及びアルコールを含む、活性成分の制御放出のためのゲル形態の医薬組成物
ES2983432T3 (es) Composición para el tratamiento y/o la prevención de la vestibulodinia
JP2007077150A (ja) 酸−酸緩衝系を含有する無水組成物
JP2020533321A (ja) クロロプロカインの表面麻酔製剤
WO2024118019A1 (en) Dermal thermosensitive gel formulations for the treatment of inflammation-related edema and various pains
RU2624866C1 (ru) Гель с оксиметилурацилом, хлоргексидином и лидокаином для проведения диагностических и лечебных эндоуретральных процедур
CN115624520A (zh) 一种地奥司明乳膏剂和应用
EP3656378A1 (en) New composition of amide and ester local anesthetics and uses thereof
WO2026027744A1 (en) Compositions for the prevention of urinary tract infections

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20121031

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160329

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20161214

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20170925

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20171025

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20171025

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20201006

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20201006

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20211006

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20211006

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20221005

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20221005

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20241219

Start annual number: 8

End annual number: 8